Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133440) titled 'A Follow-up Study of Serum 17-Hydroxyprogesterone in Patients with Spermatogenic Failure' on Sept. 28.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai General Hospital
Condition:
Spermatogenic failure
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: 17-OHP observational cohort:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344849
Published by HT Digital Content Services with permission from Health Daily Digest....